This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Werewolf Therapeutics, Inc.
Market Cap (USD):
$90.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Adicet Bio, Inc.
Market Cap (USD):
$87.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Assembly Biosciences, Inc.
Market Cap (USD):
$87.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aclaris Therapeutics, Inc.
Market Cap (USD):
$85.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Eton Pharmaceuticals, Inc.
Market Cap (USD):
$85.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
AzurRx BioPharma, Inc.
Market Cap (USD):
$82.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
AlloVir, Inc.
Market Cap (USD):
$80.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Decibel Therapeutics, Inc.
Market Cap (USD):
$80.3 M
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ikena Oncology, Inc.
Market Cap (USD):
$80.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Checkpoint Therapeutics, Inc.
Market Cap (USD):
$80.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
PMV Pharmaceuticals, Inc.
Market Cap (USD):
$78.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
CASI Pharmaceuticals, Inc.
Market Cap (USD):
$76.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Leap Therapeutics, Inc.
Market Cap (USD):
$76.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Biostage, Inc.
Market Cap (USD):
$75.9 M
(Jan. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Chimerix, Inc.
Market Cap (USD):
$74.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
FibroGen, Inc.
Market Cap (USD):
$71.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Spero Therapeutics, Inc.
Market Cap (USD):
$70.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
MediciNova, Inc.
Market Cap (USD):
$69.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Kronos Bio, Inc.
Market Cap (USD):
$69.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Champions Oncology, Inc.
Market Cap (USD):
$68.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sangamo Therapeutics, Inc.
Market Cap (USD):
$67.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Verastem, Inc.
Market Cap (USD):
$66.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Biotech Products Services and Research, Inc.
Market Cap (USD):
$66.1 M
(Nov. 1, 2021)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Instil Bio, Inc.
Market Cap (USD):
$66.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aerpio Pharmaceuticals, Inc.
Market Cap (USD):
$66.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Marinus Pharmaceuticals, Inc.
Market Cap (USD):
$65.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
CEL-SCI Corporation
Market Cap (USD):
$65.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Allakos Inc.
Market Cap (USD):
$64.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BioAtla, Inc.
Market Cap (USD):
$63.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Gritstone bio, Inc.
Market Cap (USD):
$63.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology